Evidence base: Ménière's disease

Find all the latest information about guidelines, online resources and key texts on the management of Ménière's disease

Patients with Ménière’s disease may be offered a hearing aid (Photograph: SPL)
Patients with Ménière’s disease may be offered a hearing aid (Photograph: SPL)

Clinical trials
Several Cochrane reviews have been published on various treatments for Ménière's disease.

The drug betahistine hydrochloride has been used to reduce the frequency and severity of the attacks. While this drug is very acceptable to patients who use it, the review of clinical trials did not find enough evidence to show whether it is helpful.1

The authors of another systematic review on the use of diuretics carried out an extensive search but could not identify any RCTs of sufficient quality and concluded that there was no good evidence about the effect of diuretics on the symptoms of Ménière's disease.2

Conversely, chemical labyrinthectomy with gentamicin was regarded as an effective treatment for vertigo complaints in Ménière's disease, but carried a risk of increasing hearing loss. 3

Despite an extensive search the review authors only found two RCTs studying surgical interventions for Ménière's disease.4 The two trials included in the review on surgical treatments for Ménière's disease concluded that there was insufficient evidence of the beneficial effect of endolymphatic sac surgery.

Guidelines
There is no uniformly accepted evidence-based treatment protocol given the pathophysiology of Ménière's disease.

Other factors responsible for the lack of a uniform treatment protocol include the fluctuating nature of this disease, with spontaneous, potentially long-term remissions, the frequent but poorly understood overlap with conditions such as migraine, and the high placebo effect of treatment. As such, no guidelines on Ménière's disease are available from NICE or SIGN.

Curriculum

This topic is covered in the GP curriculum in statement 15.4: ENT and facial problems

More online

This summary helps patients understand Ménière's disease.

Surgical procedures for selected patients with Ménière's disease.

References
1. James A, Burton MJ. Betahistine for Ménière's disease or syndrome. Cochrane Database Syst Rev 2001, Issue 1. Art No CD001873. DOI: 10.1002/14651858.CD001873.

2. Burgess A, Kundu S. Diuretics for Ménière's disease or syndrome. Cochrane Database Syst Rev 2006, Issue 3. Art No CD003599. DOI: 10.1002/14651858.CD003599.pub2.

3. Pullens B, van Benthem PP. Intratympanic gentamicin for Ménière's disease or syndrome. Cochrane Database Syst Rev 2011, Issue 3. Art No CD008234. DOI: 10.1002/14651858.CD008234.pub2.

4. Pullens B, Giard JL, Verschuur HP et al. Surgery for Ménière's disease. Cochrane Database Syst Rev 2010, Issue 1. Art No CD005395. DOI: 10.1002/14651858.CD005395.pub2.

 

Contributed by Mr Samuel Leong, specialist registrar in otorhinolaryngology - head and neck surgery, University Hospital Aintree, Liverpool



 


Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

BMA demands meeting with Hancock over 'unrealistic demands' on GPs

BMA demands meeting with Hancock over 'unrealistic demands' on GPs

GP leaders at the BMA have demanded an urgent meeting with health and social care...

Join MIMS Learning Live June for four nights of clinical learning

Join MIMS Learning Live June for four nights of clinical learning

Across the MIMS Learning Live Digital series our expert speakers will bring you updates...

GP careers: The GP who helps defend doctors

GP careers: The GP who helps defend doctors

Dr John Dale-Skinner combines a salaried GP post with medico-legal work as a senior...

Map: Which CCGs have the highest COVID-19 vaccine coverage?

Map: Which CCGs have the highest COVID-19 vaccine coverage?

Tens of millions of COVID-19 jabs have been administered across England, but how...

GMC targets elimination of 'shameful' bias in regulation and education

GMC targets elimination of 'shameful' bias in regulation and education

The GMC has set a five-year target for eliminating disproportionate complaints from...

Viewpoint: False claims about GP access must be challenged - or practices really will close

Viewpoint: False claims about GP access must be challenged - or practices really will close

A high-profile public campaign is vital to counter damaging, false claims that GP...